Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Alligo: Tooled up for continued margin recovery - ABG

ALLIGO BThird party research08.10.2026, 07.08

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
* Q3e: Sales SEK 2,346m and adj. EBITA SEK 177m
* Estimates trimmed by 4/2% for '26e/'27e
* 12x/10x '26e/'27e adj. EBITA

Q3 expectations

We expect the company to deliver sales of SEK 2,346m, up 7% y-o-y (3% organic, 2% FX and 2% M&A). We forecast an adj. EBITA of SEK 177m, +12% y-o-y, for a margin of 7.5%. We are cautiously optimistic on Sweden. While we see tough comps ahead in Q3'26, as Q3'25 marked the start of the recovery in the market and a return to earnings growth after a prolonged downturn, we also see positive data points. The Swedish building material index increased 9.5% in Q2 (its highest since Q1'22) and Swedish manufacturing PMI sat at a solid 58.1 in September. We expect the market in Norway to remain similar to H1, with subdued oil and gas activity (~7% of group sales) as large offshore developments near completion. This should be partly offset by Q3 historically being a seasonally stronger quarter for margins. We remain upbeat on further margin improvement in Finland, driven by a stronger industrial cycle and high defence exposure.

Estimates lowered by 4/2% for '26e/'27e

We make only minor revisions to our sales estimates but lower our '26e-27e adj. EBITA by 4/2%, mainly due to revised margin assumptions for Sweden following a change of analyst. We reduce Sweden’s '26e adj. EBITA margin to 9.2% from 9.7% and trim Finland’s by 12bps. Meanwhile, favourable FX effects lift our Norwegian earnings estimates by 2-4%. We expect activity in Norway to remain low but stable in H2.

Share trading at 12x/10x '26e/'27e adj. EV/EBITA

We continue to see the margin recovery story as appealing and are encouraged by management's communication. The share is currently trading at 11.7/9.6x '26e/'27e adj. EV/EBITA. Returning -6% the L3M, it has underperformed OMXSALLS which has returned +1%. The Q3 report is due on Friday 23 October.